ALLMedicine™ Thyroiditis Center
Research & Reviews 2,268 results
https://doi.org/10.1097/MD.0000000000033205
Medicine Jia C, Zhang L et. al.
Mar 18th, 2023 - To investigate glucose and lipid metabolism in patients with polycystic ovary syndrome (PCOS) with and without Hashimoto's thyroiditis (HT). In the present study, 103 women were included as controls and a total of 213 patients (49 patients with HT...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016297
BMJ Case Reports; Yamazaki D, Osaki Y et. al.
Mar 15th, 2023 - We report a rare case of takotsubo cardiomyopathy caused by subacute thyroiditis in a man in his 50s. He went to the doctor with complaints of loss of appetite, diarrhoea, chills and general malaise. He had consciousness disturbance, thyrotoxicosi...
https://doi.org/10.1016/j.beem.2023.101773
Best Practice & Research. Clinical Endocrinology & Metabo... Ferrari SM, Paparo SR et. al.
Mar 13th, 2023 - The chemokine receptor CXCR3 and its chemokines CXCL9, CXCL10, and CXCL11 are involved in the pathogenesis of autoimmune diseases. Th1 lymphocytes are recruited by Th1 chemokines, secreted by damaged cells. In inflamed tissues, the attracted Th1 l...
https://doi.org/10.1016/j.critrevonc.2023.103957
Critical Reviews in Oncology/hematology; Ma Y, Zhang Q et. al.
Mar 13th, 2023 - Thyroid cancer is the most common endocrine cancer. Neurotrophic tyrosine receptor kinase (NTRK) fusions are oncogenic drivers in multiple solid tumors, including thyroid cancer. NTRK fusion thyroid cancer has unique pathological features such as ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007734
Journal of Medical Case Reports; Ajmi H, Bouafsoun C et. al.
Mar 11th, 2023 - Patients with Down syndrome are at a higher risk of developing autoimmune disorders such as thyroiditis, diabetes, and celiac disease compared with the general population. Although some diseases are well known to be associated with Down syndrome, ...
Guidelines 1 results
https://doi.org/10.1007/s00520-020-05709-1
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Girotra M et. al.
Aug 29th, 2020 - Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment, transforming outcomes in melanoma and showing benefit in a range of malignancies. Immune-mediated toxicities, stemming from increased activity within the T ...
Drugs 790 results see all →
Clinicaltrials.gov 84 results
https://clinicaltrials.gov/ct2/show/NCT00194298
Mar 6th, 2023 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...
https://clinicaltrials.gov/ct2/show/NCT04656873
Feb 15th, 2023 - BACKGROUND Tumors evolve to evade the body's anti-tumor immune response by targeting cancer cells and downregulating immune pathways. Immune checkpoint inhibitors (ICIs) prevent this tumor evasion by driving the immune system into an "activated st...
https://clinicaltrials.gov/ct2/show/NCT05715970
Feb 8th, 2023 - Background The diagnosis of celiac disease (CD), a known autoimmune disease, presupposes the recognition of symptoms/signs, the carrying out of serological tests and the diagnostic confirmation with histological examination of intestinal biopsies....
https://clinicaltrials.gov/ct2/show/NCT05717933
Feb 8th, 2023 - Type-I diabetes mellitus is an auto immune disease. It is the most common type of diabetes in children and adolescents. It is also the most common chronic disease in children in the developed countries. The illness is characterized by the body's i...
https://clinicaltrials.gov/ct2/show/NCT05658809
Dec 21st, 2022 - Thyroid nodular disease comprises of a wide range of disorders. Benign forms such as colloid nodules,cysts and thyroiditis are more comman than benign follicular neoplasms and thyroid carcinomas. Incidence of malignancy ranges from 10% to 30% in s...
News 285 results
https://www.onclive.com/view/immunotherapy-and-you-gynecologic-treatment-efficacy-from-a-patient-s-perspective
Nov 10th, 2022 - In this second episode of OncChats: Immunotherapy and You, John Nakayama, MD, of the Division of Gynecologic Oncology, Allegheny Health Network, and assistant professor of OBGYN at Drexel University, and Ali Amjad, MD, medical hematologic oncologi...
https://www.medscape.com/viewarticle/983254
Oct 31st, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Dr Ilaria Muller MONTREAL — Patients hospitalized with severe COVID-19 and no prior history of thyroid dysfunction show signs of thyroiditis that,...
https://www.onclive.com/view/immunotherapy-based-endeavors-could-alter-treatment-landscape-in-metastatic-tnbc
Oct 24th, 2022 - Triple-negative breast cancer (TNBC) remains a difficult-to-treat subtype within the breast cancer population. However, immunotherapy-based approaches could eventually help improve outcomes and long-term prognosis for these patients, according to ...
https://www.onclive.com/view/gx-188e-plus-pembrolizumab-proves-safe-effective-in-hpv16-18-recurrent-or-metastatic-cervical-cancer
Oct 13th, 2022 - The therapeutic DNA vaccine, GX-188E, in combination with pembrolizumab (Keytruda) produced encouraging responses in patients with human papillomavirus (HPV) 16- or 18-positive, recurrent or metastatic cervical cancer who did not respond to standa...
https://www.mdedge.com/obgyn/article/258536/gynecology/disjointed-states-america-medical-political
Sara Neill, MD, MPH
Oct 10th, 2022 - Like many of you, I am an obstetrician-gynecologist who provides full-spectrum reproductive health care. Our jobs demand great intimacy—we are with patients as they meet their first born, learn of a miscarriage diagnosis, or decide to end their pr.